Deep Brain Stimulation for Bipolar Depression

This trial explores a new method to assist individuals with bipolar disorder who have not found relief from depression with other treatments. Researchers are testing the Medtronic Percept PC DBS system, a device that uses deep brain stimulation to manage depression and prevent mood swings by sending electrical impulses to specific brain areas. To ensure the treatment's safety, the trial monitors brain activity to track depression and predict mania. Suitable candidates for this trial have Bipolar I Disorder, have experienced depression for at least a year despite trying several treatments, and have stable mood control without recent manic episodes. As an unphased trial, this study provides a unique opportunity to explore innovative treatment options for those seeking new solutions.

A previous study found that Deep Brain Stimulation (DBS) was generally well-tolerated by most patients. DBS involves placing small wires in specific brain areas to treat conditions like Parkinson's disease and, more recently, some mental health issues. For bipolar disorder, the target area is the Subcallosal Cingulate (SCC) region of the brain. Although using DBS for bipolar disorder is new, the technique has been applied to other conditions before.

Most treatments for bipolar depression, like mood stabilizers and antipsychotics, work by altering neurotransmitter levels. But the Medtronic Percept PC DBS system works differently, targeting specific brain areas directly through electrical stimulation. This deep brain stimulation method is unique because it provides continuous local field potential monitoring from the subcallosal cingulate and amygdala, potentially allowing for more precise regulation of brain activity related to mood. Researchers are excited about this approach because it offers a new way to manage symptoms for those who might not respond well to traditional medications.

Research has shown that Deep Brain Stimulation (DBS) can help treat severe depression. Studies found that 40-60% of people with depression experienced lasting relief from their symptoms with DBS. Specifically, after just two weeks of treatment, more than half of the patients showed a 47% reduction in their depression scores. Additionally, a long-term study revealed that 71% of patients with severe depression improved. This trial will specifically evaluate the use of DBS for bipolar depression, suggesting it could be a promising treatment option for participants.⁶⁷⁸⁹¹⁰